The Full Endpoint Spectrum. One Partner.
Strados now delivers the full spectrum of respiratory endpoints — cough monitoring, remote spirometry, FeNO, lung sound analysis, and eCOA — as a single specialist partner. Leveraging Strados' respiratory intelligence and incorporating the validated clinical trial capabilities of NuvoAir.
Peer-reviewed in
Hours of Respiratory Data
Peer-Reviewed Publications
Clinical Studies
Countries
Sites
Integrated Endpoint Suite
The Strados Endpoint Suite
Next-generation, medical-grade technology designed to deliver the most accurate and patient-friendly respiratory monitoring available.
The Strados Intelligence Advantage
Respiratory Endpoint Intelligence
How Strados brings AI, proprietary biosensing, and human expertise together to produce regulatory-grade respiratory evidence in the real world.
Continuous by design.
Episodic clinic visits miss the disease burden that lives between appointments. Strados captures what matters — continuously in patients' daily lives — for every endpoint in the suite.
Retained. Reviewable. Auditable.
AI detects. Experts review. Audio is retained. The full evidence chain — from capture to annotation to audit — is preserved and accessible. This is what separates Strados from algorithm and human review-only solutions.
Intelligence is the standard, not a feature.
Every data point we deliver is traceable, defensible, and built for regulatory submission. Not just processed and reported — but reviewed, annotated, and audit-ready from the moment it is captured.
Trusted Globally
Trusted by leading pharma sponsors and respiratory CRO partners across Phase I–III clinical trials in 34 countries.
"We needed a partner who could support our global cough endpoint study with the rigour our regulatory team required. Strados delivered."
— Clinical Operations Lead, Phase II ILD program
Built for Your Program
Who we work with
For Sponsors
Comprehensive Endpoints. One relationship.
Strados delivers every respiratory endpoint your program needs — cough monitoring, spirometry, FeNO, lung sound analysis, and eCOA — through a single specialist partner. One contract, one data stream, one point of accountability. Scientifically validated, GCP-compliant, and built for regulatory submission.
Design a StudyFor CROs
The respiratory specialist your sponsors are asking for.
Strados is the single integration point for all respiratory endpoints in complex multi-modal programs. Complementary to — not competing with — your broader eClinical infrastructure. Phase I–III delivery experience across 34 countries, with full site support, device logistics, and GCP-compliant data.
Explore CRO PartnershipWhy Strados
Why Partner with Strados?
We live and breathe respiratory.
Patient and physician founded, dedicated to making every breath count. We're committed to improving quality of life for patients with respiratory diseases.
Innovation is in our DNA.
We built the world's first FDA-cleared device to continuously capture lung sounds. That breakthrough wasn't a one-time event — it reflects how we think. We are always ahead of where the science is going, not catching up to where it's been.
Scientific rigor, regulatory grade.
FDA 510(k) cleared devices, validated algorithms, retained audio, GCP-compliant processes, and expert overread at every step. Built for pivotal trials from day one — not adapted for them after the fact.
Continuous real-world data.
Capture what happens between clinic visits — the moments that matter most for understanding how patients actually respond to treatment. Ambulatory, continuous, and reflective of real disease burden.
Patient-centered by design.
Low-burden wearables and home-based assessments that fit into patients' daily lives. We measure what matters to patients — not just what's convenient to collect at a clinic visit.
One partner. No gaps.
Eliminate fragmented vendor relationships. Cough, spirometry, FeNO, lung sounds, and eCOA — one platform, one data stream, one specialist partner across every respiratory endpoint your program needs.
Our Collaborators
Partners
Stay Informed
News & Resources
Strados Labs Completes Acquisition of NuvoAir's Clinical Trial Business
Creating the first full-spectrum respiratory endpoint intelligence company, uniting validated remote spirometry, FeNO, and eCOA with gold-standard cough monitoring and lung sound analysis.
Read more
Strados Labs Announces Study Evaluating Remote Lung Sound Monitoring to Predict COPD Exacerbations
The SHORE study, in collaboration with Jefferson Health, will assess the feasibility of home-based, continuous monitoring of cough and lung sounds following COPD exacerbations.
Read more
How Can Monitoring Cough & Lung Sounds Add Value in Respiratory Clinical Trials?
Sponsors increasingly recognize that relying solely on pulmonary function tests and patient-reported outcomes leaves critical insight on the table.
Read more
Ready to design your respiratory study?
Tell us about your program and we'll help you design the right respiratory endpoint strategy.
Design a Study
